Evidence map›Paper›PMID 40631559›Full record

ArticleAdvanced biology2025

Forskolin Enhances Urokinase Plasminogen Activator Secretion and Angiogenic Activity of Xeno-Free Cultures of Human Adipose Tissue-Derived Stem Cells.

Maria Vittoria Giraudo, Anne Therese Lauvrud, Rebecca Wiberg, Maria Brohlin, Gustav Andersson, Paul J Kingham

Abstract read
In one paragraph

Article in Advanced biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Vittoria GiraudoDepartment of Medical and Translational Biology, Umeå University, Umeå, 90187, Sweden.
Anne Therese LauvrudDepartment of Medical and Translational Biology, Umeå University, Umeå, 90187, Sweden.
Rebecca WibergDepartment of Medical and Translational Biology, Umeå University, Umeå, 90187, Sweden.
Maria BrohlinDepartment of Medical and Translational Biology, Umeå University, Umeå, 90187, Sweden.
Gustav AnderssonDepartment of Medical and Translational Biology, Umeå University, Umeå, 90187, Sweden.
Paul J KinghamDepartment of Medical and Translational Biology, Umeå University, Umeå, 90187, Sweden.ORCID 0000-0003-2596-5936

Funding

Medicinska fakulteten, Umeå Universitet ForskningslyftetMedicinska fakulteten, Umeå Universitet InsamlingsstiftelsenMedicinska fakulteten, Umeå Universitet Strategic-Research-Resources-GrantUmeå University and Västerbotten County Council ALFVinnova 2017-02130Wallenberg Centre for Molecular Medicine RV-769441
6 · The paper itself

Abstract

Adipose tissue-derived stem cells (ASCs) hold significant potential for treating various clinical conditions. To enhance their regenerative properties, ASCs can be chemically stimulated using various in vitro protocols. However, unsatisfactory results persist, partly due to the relatively costly long-term methods. Furthermore, current culturing techniques often rely on the use of xenogenic fetal bovine serum that can be immunogenic, limiting clinical translations. To facilitate clinical translation of ASCs-derived therapeutics, the effect of different stimulation protocols on human ASCs cultured in a xeno-free medium (PRIME-XV MSC Expansion XSFM) is investigated. The xeno-free medium was supplemented with stimulants (forskolin (FSK), basic fibroblast growth factor, platelet-derived growth factor-AA, neuregulin-1) in combinations or individually. Stimulation for 72 h in FSK alone, or together with the growth factors, enhanced the production of urokinase plasminogen activator (uPA), a serine protease involved in tissue remodeling processes. Conditioned medium derived from stimulated ASCs enhanced in vitro angiogenesis and endothelial cells migration. This study shows that pro-angiogenic responses in human ASCs can be enhanced with a defined short stimulation protocol using a xeno-free medium. The protocol, using readily available manufacturing cell therapy grade molecules, may boost the regenerative properties of ASCs secretome which could enhance their efficacy in clinical treatments.

Indexed as

Adipose TissueColforsinNeovascularization, PhysiologicStem CellsUrokinase-Type Plasminogen ActivatorCells, CulturedCulture Media, ConditionedFibroblast Growth Factor 2HumansColforsinCulture Media, ConditionedFibroblast Growth Factor 2Urokinase-Type Plasminogen Activatorangiogenesisgrowth factorsmesenchymal stem cellssecretomexeno‐free culture

Identifiers

PMID40631559
PMCPMC12517313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.